Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 55 min 19 sec ago

GW Pharmaceuticals Initiates Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome

Mon, 05/11/2015 - 14:03
LONDON, May 11, 2015 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing n...
Biopharmaceuticals, Neurology
GW Pharmaceuticals, cannabinoid, Epidiolex, Lennox-Gastaut syndrome

Roche Receives FDA Approval for cobas(R) KRAS Mutation Test

Mon, 05/11/2015 - 13:58
Molecular PCR test identifies KRAS mutations to aid in determining therapy for metastatic colorectal cancer> PLEASANTON, Calif., May 11, 2015 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U....
Diagnostics, Oncology, FDA
Roche Group, cobas KRAS, KRAS , metastatic colorectal cancer

Nephros Appoints Malcolm Persen to Board of Directors

Fri, 05/08/2015 - 15:57
RIVER EDGE, N.J.--(Healthcare Sales & Marketing Network)--Nephros, Inc. (NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use...
Devices, Personnel
Nephros, hemodiafiltration, hemodialysis

Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development

Fri, 05/08/2015 - 15:53
MENLO PARK, Calif., May 8, 2015 -- (Healthcare Sales & Marketing Network) -- Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced the appointment of Andrew C. Lam as Vice Pr...
Biopharmaceuticals, Cardiology, Personnel
Armetheon, Tecarfarin, Vitamin K, Vitamin K Antagonist

Provectus Biopharmaceuticals Updates Market on Business Developments

Fri, 05/08/2015 - 15:50
Form 10-Q Filed on Thursday, May 7 Enrollment Open for Phase 3 PV-10 Melanoma Study Patent Protections Expanded in Europe and Japan KNOXVILLE, Tenn.--(Healthcare Sales & Marketing Network)--Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, htt...
Biopharmaceuticals, Dermatology, Oncology
Provectus Biopharmaceuticals, psoriasis

RaySearch Laboratories: First Proton Treatments with RayStation and MEVION S250

Wed, 05/06/2015 - 15:14
Ackerman Cancer Center in Jacksonville, Florida treats its first patient with the MEVION S250 and the RayStation® Treatment Planning System STOCKHOLM--(Healthcare Sales & Marketing Network)--On April 30, 2015 a major milestone was reached at Ackerma...
Devices, Oncology, Product Launch
RaySearch Laboratories, MEVION, proton therapy, treatment planning, radiotherapy

Gilead Sciences Acquires EpiTherapeutics

Wed, 05/06/2015 - 15:10
Deal Adds Small Molecule Inhibitors against Targets Involved in Epigenetic Regulation FOSTER CITY, Calif. & COPENHAGEN, Denmark--(Healthcare Sales & Marketing Network)--Gilead Sciences, Inc. (GILD) and EpiTherapeutics ApS, a privately-held Danish compan...
Biopharmaceuticals, Oncology, Mergers & Acquisitions
Gilead Sciences, EpiTherapeutics, histone demethylase

EMD Serono Initiates Co-Promotion of XALKORI(R) (crizotinib) with Pfizer in the United States

Wed, 05/06/2015 - 15:07
Marks first commercial oncology milestone for EMD Serono through the global strategic alliance between Merck KGaA, Darmstadt, Germany and Pfizer Expands on EMD Serono strategy and deep expertise in addressing unmet needs in specialty care ROCKLAND, M...
Biopharmaceuticals, Oncology, Distribution
EMD Serono, Merck KGaA, Pfizer, XALKORI, crizotinib, non-small cell lung cancer

Presbia Announces the Appointment of John Strobel as Vice President of Sales

Tue, 05/05/2015 - 13:54
DUBLIN--(Healthcare Sales & Marketing Network)--Presbia PLC (LENS), an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today the ...
Devices, Ophthalmology, Personnel
Presbia PLC, Flexivue Microlens

Transcend Medical Announces Intent to File Premarket Approval Application With FDA for the CyPass(R) Glaucoma Micro-Stent

Tue, 05/05/2015 - 13:37
Pivotal COMPASS Trial Reveals Positive Results Through Two Years for Novel Micro-Stent MENLO PARK, CA--(Healthcare Sales & Marketing Network) - Transcend Medical, Inc. announced today its intent to file a premarket approval (PMA) application with the U...
Devices, Ophthalmology, FDA
Transcend Medical, CyPass, Micro-Stent, Glaucoma

OMEICOS Appoints Dr. Ulrich Dauer as Chief Executive Officer

Tue, 05/05/2015 - 13:30
BERLIN--(Healthcare Sales & Marketing Network)--OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation (AF), today an...
Biopharmaceuticals, Cardiology, Personnel
OMEICOS Therapeutics, atrial fibrillation

St. Jude Medical Completes Acquisition of Spinal Modulation, Inc.

Mon, 05/04/2015 - 15:24
Now complete, the acquisition of Spinal Modulation adds DRG stimulation technology to the St. Jude Medical chronic pain portfolio ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, tod...
Devices, Neurology, Mergers & Acquisitions
St. Jude Medical, Spinal Modulation, Axium, Neurostimulator, neuromodulation

FDA Clears Invictus Medical’s GELShield(TM) for Market Launch

Mon, 05/04/2015 - 15:16
SAN ANTONIO--(Healthcare Sales & Marketing Network)--Invictus Medical, the San Antonio, Texas-based medical device company dedicated to providing newborns with healthy developmental milestones, has received Food and Drug Administration (FDA) clearance to b...
Devices, FDA
Invictus Medical, GELShield, extracranial pressure

Alphatec Spine Announces Appointment of Donald A. Williams to its Board of Directors

Fri, 05/01/2015 - 15:02
CARLSBAD, Calif., May 1, 2015 -- (Healthcare Sales & Marketing Network) -- Alphatec Holdings, Inc. (ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that its board of directors has appointe...
Devices, Orthopaedic, Neurosurgery, Personnel
Alphatec, Alphatec Spine, spinal fusion, spine surgery

Advanced Inhalation Therapies Granted European Orphan Drug Designation for Nitric Oxide for the Treatment of Cystic Fibrosis

Fri, 05/01/2015 - 14:44
REHOVOT, Israel and NEW YORK, May 1, 2015 -- (Healthcare Sales & Marketing Network) -- Advanced Inhalation Therapies Ltd (AIT), a leading anti-microbial therapeutic company, announced that the European Commission, acting on the recommendation from the Com...
Biopharmaceuticals, Regulatory
Advanced Inhalation Therapies, AIT-CF, nitric oxide, cystic fibrosis

St. Jude Medical Receives FDA Approval for the World’s Smallest Upgradeable MR-Conditional Spinal Cord Stimulation System

Thu, 04/30/2015 - 16:30
New approval for the Protégé MRI system ensures patient access to upgradeable technology while removing a traditional barrier to SCS therapy ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global m...
Devices, Neurology, FDA
St. Jude Medical, Protégé MRI, spinal cord stimulation, neuromodulation

ConvaTec Appoints Paul Moraviec CEO Effective April 30, 2015

Thu, 04/30/2015 - 16:25
LUXEMBOURG, April 30, 2015 -- (Healthcare Sales & Marketing Network) -- ConvaTec, a privately-held medical products and technologies company, today announced that Paul Moraviec has been appointed Chief Executive Officer of the company. Mr. Moraviec was...
Devices, Personnel

SurgiQuest Names Jaime Landman, M.D. Chief Medical Director

Wed, 04/29/2015 - 14:47
MILFORD, Conn., April 29, 2015 -- (Healthcare Sales & Marketing Network) -- SurgiQuest, Inc. ("SurgiQuest" or the "Company"), a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced th...
Devices, Personnel
SurgiQuest, AirSeal iFS System

CyMedica Orthopedics Launches The QB1 System - A Proprietary Device For Treatment Of Quadriceps Atrophy - At AANA

Wed, 04/29/2015 - 14:29
SCOTTSDALE, Ariz., April 29, 2015 -- (Healthcare Sales & Marketing Network) -- Scottsdale-based CyMedica Orthopedics™, Inc. announced the commercial launch of the CyMedica QB1™ System for the treatment of quadriceps muscle atrophy at the Arthroscopy Assoc...
Devices, Orthopaedic, Product Launch
CyMedica Orthopedics, CyMedica QB1, quadriceps atrophy

Intact Vascular’s First-In-Man Clinical Study Results Published in the Journal of the American College Of Cardiology: Cardiovascular Interventions

Wed, 04/29/2015 - 13:48
Early Experimental and Clinical Experience with a Focal Implant (Tack Endovascular System) for Lower Extremity Post-Angioplasty Dissection Suggests a Safe and Feasible Alternative Treatment WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Intact Vasc...
Devices, Interventional
Intact Vascular, Tack Endovascular System

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong